The authors further explored its effects on anti-tumor immunity, demonstrating that semaglutide enhanced the activation and cytotoxicity of CD8+ T cells within the tumor microenvironment, modulated macrophage polarization towards a pro-inflammatory, M1-phenotype, and increased infiltration and activation of B cells, contributing to a more robust immune response. This evidence concerns the gene CD8A and neoplasm.